CHI3L1 and neoplasm: Due to the limited number of samples in our previous data set, we purified astrocytes from an independent cohort (ctr n = 8, TAA n = 9) and validated the CHI3L1 expression by RT-qPCR, which confirmed a significant increase of CHI3L1 expression in tumor-associated astrocytes.